STING1 and breast cancer: Patients with sustained high expression of STING before and after NAC had a significantly poorer prognosis than that of others for distant recurrence‐free survival and breast cancer‐specific survival independent of nodal status, lymphatic invasion and therapeutic effects (p = 0.024 and 0.014, respectively).